After three doses of the PD-1 neutralizing antibody, the liver tumor was significantly inhibited in the Stat3 flox/floxAlb-cre+ HCC model as compared to the Stat3 flox/floxAlb-cre- model (Fig. 7g). Here, STAT3 is linked to hepatocellular carcinoma.